American College of Physicians: Internal Medicine — Doctors for Adults ®

Advertisement

FDA News



New COPD treatment, warnings on insomnia and migraine drugs

This regulatory update covers approval of a combined long-term maintenance treatment for chronic obstructive pulmonary disease, warnings against driving after taking insomnia drugs and on use of migraine drugs in pregnant women, and more. More

New dosing for ESAs and oseltamivir, warning on pioglitazone

Recalls, warnings, approvals and other regulatory news. More

Recalls target cold products, digoxin, defribrillators, diet aids

A summary of approvals, recalls, warnings and alerts. More

Recalls for arrhythmia drug, infusion pumps, defibrillators

A summary of approvals, recalls, warnings and alerts from the Food and Drug Administration. More

Boxed warning for metoclopramide, alert for zonisamide

A summary of approvals, recalls, warnings and alerts. More

Peanut butter recall issued, reminder for topical anesthetics

A summary of approvals, recalls, warnings and alerts. More

FDA review: new blood tests and blood-loss products (November/December 2007)

FDA review: phosphate binders, drug-eluting stents (October 2007)

FDA review: Anemia drugs, aprotinin on panel's agenda (September 2007)

Top

This is a printer-friendly version of this page

Print this page  |  Close the preview

Share

 
 

Internist Archives Quick Links

ACP Clinical Shorts

Expert Education on Your Schedule

Short videos deliver highly focused answers to challenging clinical situations seen in practice and are a terrific way to earn CME credit on-the-goShort videos deliver highly focused answers to challenging clinical situations seen in practice and are a terrific way to earn CME credit on-the-go. See more.

New: Free Modules from ACP Practice Advisor!

New: Free Modules from ACP Practice Advisor!

Keep your practice moving in the right direction. ACP Practice Advisor is offering four modules that you and your staff can try for free. Get to know the premier online practice management tool at no risk. Explore the modules.